sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
RYTM
Updated 10/6/2026, 11:57 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | $5,133,442 | Meeker David P President and CEO, Director | 50,000 sh | at $102.67 | Filed Sep 14, 7:37 PM ET | Filing | |
| RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | $6,619,913 | Smith Hunter C Chief Financial Officer | 62,774 sh | at $105.46 | Filed Sep 1, 4:22 PM ET | Filing | |
| RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | $608,210 | Shulman Joseph Chief Technical Officer | 5,079 sh | at $119.75 | Filed Aug 17, 6:00 PM ET | Filing | |
| RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | $912,703 | Garfield Alastair Chief Scientific Officer | 7,763 sh | at $117.57 | Filed Aug 17, 5:57 PM ET | Filing | |
| RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | $8,901,531 | Lee Jennifer Kayden EVP, Head of North America | 75,834 sh | at $117.38 | Filed Aug 14, 7:04 PM ET | Filing | |
| RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | $6,620,575 | Mazabraud Yann EVP, Head of International | 57,000 sh | at $116.15 | Filed Aug 14, 7:01 PM ET | Filing |